Your browser doesn't support javascript.
loading
Comparison of Dimethyl Fumarate vs Fingolimod and Rituximab vs Natalizumab for Treatment of Multiple Sclerosis.
Hou, Jue; Kim, Nicole; Cai, Tianrun; Dahal, Kumar; Weiner, Howard; Chitnis, Tanuja; Cai, Tianxi; Xia, Zongqi.
Afiliação
  • Hou J; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
  • Kim N; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
  • Cai T; Division of Rheumatology, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
  • Dahal K; Division of Rheumatology, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
  • Weiner H; Department of Neurology, Brigham and Women's Hospital, Boston, Massachusetts.
  • Chitnis T; Department of Neurology, Brigham and Women's Hospital, Boston, Massachusetts.
  • Cai T; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
  • Xia Z; Department of Biomedical Informatics, Harvard Medical School, Boston, Massachusetts.
JAMA Netw Open ; 4(11): e2134627, 2021 11 01.
Article em En | MEDLINE | ID: mdl-34783826
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esclerose Múltipla Recidivante-Remitente / Cloridrato de Fingolimode / Fumarato de Dimetilo / Natalizumab / Rituximab / Esclerose Múltipla Tipo de estudo: Etiology_studies / Prognostic_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: JAMA Netw Open Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esclerose Múltipla Recidivante-Remitente / Cloridrato de Fingolimode / Fumarato de Dimetilo / Natalizumab / Rituximab / Esclerose Múltipla Tipo de estudo: Etiology_studies / Prognostic_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: JAMA Netw Open Ano de publicação: 2021 Tipo de documento: Article